Arcadia Biosciences, a trailblazer in the realm of agricultural biotechnology, has made significant strides in the cannabis industry by focusing on the development of high-quality, sustainable plant products. Established in 2002, the company initially aimed to enhance crop productivity and environmental sustainability. However, as the cannabis market burgeoned, Arcadia Biosciences shifted gears to apply its #1excludeGlossary technologies to cannabis cultivation. The name “Arcadia” is derived from a pastoral region in ancient Greece, often associated with unspoiled wilderness and natural beauty, reflecting the company’s commitment to eco-friendly practices. Today, Arcadia Biosciences is renowned for its innovative approaches to plant breeding and genetic improvement, ensuring that it remains a key player in the ever-evolving cannabis landscape. [Source: Arcadia Biosciences Official Website]
Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
 | |
| Company type | Public |
|---|---|
| Nasdaq: RKDA | |
| Industry | agricultural biotechnology |
| Founded | 2002 |
| Headquarters | Davis, California, United States |
Area served | Worldwide |
Key people | Matthew Plavan (Chief Executive Officer) |
| Products | GoodWheat™ |
| Revenue |
|
Number of employees | 42 |
| Website | arcadiabio |
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.